Latest Capital Structure News

Redcastle Resources Limited has announced a 10-for-1 security consolidation affecting its ordinary shares and multiple option classes, set to take effect in late 2025. This move aims to streamline the company's capital structure ahead of key upcoming milestones.

Blue Star Helium Limited is poised to become a key U.S. helium and natural CO2 producer with first production from its Galactica project scheduled for December 2025. The company’s staged development plan and strategic joint venture position it to address growing domestic helium demand amid global supply constraints.

Freehill Mining Limited has increased its capital raising to $540,000 through a share placement and free-attaching options, aiming to support its processing operations in Chile and strengthen working capital.

Audio Pixels Holdings has extended the maturity of $12.3 million in convertible notes to January 2027 and capitalised $4.05 million in accrued interest, enhancing its financial flexibility.

Jindalee Lithium has launched an options offer linked to its recent Share Purchase Plan and placements, aiming to incentivize shareholders and raise capital for its lithium development projects. The options carry an exercise price of $0.825 and expire in late 2028.

Jindalee Lithium has successfully raised $8 million through a private placement, complemented by a $1 million Share Purchase Plan, to advance its McDermitt Lithium Project and a strategic US SPAC transaction.

European Lithium Limited has launched a replacement options offer for holders of 205 million expiring options, with directors committing to fully participate and underwrite the offer pending shareholder approval at the upcoming AGM.

BCAL Diagnostics has launched a $10 million convertible note facility, with $5 million already committed, to strengthen its capital position and accelerate commercialisation of its cancer detection technologies.

Prodigy Gold has reported a milestone with over one million ounces of gold in its resource inventory, alongside significant exploration progress and a successful $7.13 million capital raise to fund ongoing development.

BCAL Diagnostics has established a $10 million convertible note facility, with $5 million already committed, to accelerate its cancer detection technologies and commercial milestones.

Botanix Pharmaceuticals reports a strong start to FY26 with a 50% surge in Sofdra prescriptions and a 65% rise in net revenue, underpinned by a larger sales team and operational efficiencies.

Shriro Holdings announces a $5 million off-market share buy-back at a 14.1% premium, signaling a pivot from acquisitions to expanding its BBQ range globally. The move aims to return excess capital to shareholders while maintaining flexibility for further buy-backs.